USP13
Basic information
Region (hg38): 3:179653032-179804366
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 44 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 46 | 0 | 2 |
Variants in USP13
This is a list of pathogenic ClinVar variants found in the USP13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-179653236-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
3-179653241-G-T | not specified | Uncertain significance (Jan 18, 2022) | ||
3-179653266-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
3-179653268-G-C | not specified | Uncertain significance (Dec 04, 2024) | ||
3-179653286-G-A | not specified | Uncertain significance (Nov 02, 2023) | ||
3-179653305-T-G | not specified | Uncertain significance (Jun 24, 2022) | ||
3-179653385-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
3-179653386-A-C | not specified | Uncertain significance (Mar 20, 2024) | ||
3-179681888-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
3-179701028-T-G | not specified | Uncertain significance (Feb 15, 2023) | ||
3-179706940-A-G | not specified | Uncertain significance (Sep 11, 2024) | ||
3-179707000-T-C | not specified | Uncertain significance (Apr 15, 2024) | ||
3-179707037-A-G | not specified | Uncertain significance (Jul 23, 2024) | ||
3-179708780-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
3-179708794-C-T | Benign (Jul 13, 2018) | |||
3-179708868-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
3-179708873-G-T | not specified | Uncertain significance (Mar 04, 2024) | ||
3-179708893-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
3-179719946-A-T | not specified | Uncertain significance (Dec 13, 2022) | ||
3-179720018-T-C | not specified | Uncertain significance (Nov 22, 2023) | ||
3-179721405-G-A | not specified | Uncertain significance (Apr 21, 2022) | ||
3-179721460-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
3-179721472-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
3-179721489-A-G | not specified | Uncertain significance (Nov 11, 2024) | ||
3-179721508-C-T | not specified | Uncertain significance (Apr 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP13 | protein_coding | protein_coding | ENST00000263966 | 21 | 136647 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.07e-12 | 0.999 | 125665 | 0 | 83 | 125748 | 0.000330 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.90 | 376 | 495 | 0.760 | 0.0000266 | 5709 |
Missense in Polyphen | 110 | 153.24 | 0.71781 | 1807 | ||
Synonymous | 0.751 | 173 | 186 | 0.930 | 0.0000110 | 1600 |
Loss of Function | 2.99 | 27 | 49.7 | 0.543 | 0.00000282 | 553 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000586 | 0.000583 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000221 | 0.000217 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.000361 | 0.000360 |
Middle Eastern | 0.000221 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Deubiquitinase that mediates deubiquitination of target proteins such as BECN1, MITF, SKP2 and USP10 and is involved in various processes such as autophagy and endoplasmic reticulum- associated degradation (ERAD). Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. Also deubiquitinates USP10, an essential regulator of p53/TP53 stability. In turn, PIK3C3/VPS34- containing complexes regulate USP13 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Recruited by nuclear UFD1 and mediates deubiquitination of SKP2, thereby regulating endoplasmic reticulum-associated degradation (ERAD). Also regulates ERAD through the deubiquitination of UBL4A a component of the BAG6/BAT3 complex. Mediates stabilization of SIAH2 independently of deubiquitinase activity: binds ubiquitinated SIAH2 and acts by impairing SIAH2 autoubiquitination. Has a weak deubiquitinase activity in vitro and preferentially cleaves 'Lys-63'-linked polyubiquitin chains. In contrast to USP5, it is not able to mediate unanchored polyubiquitin disassembly. Able to cleave ISG15 in vitro; however, additional experiments are required to confirm such data. {ECO:0000269|PubMed:17653289, ECO:0000269|PubMed:21571647, ECO:0000269|PubMed:21659512, ECO:0000269|PubMed:21811243, ECO:0000269|PubMed:21962518, ECO:0000269|PubMed:22216260, ECO:0000269|PubMed:24424410}.;
- Pathway
- Signal Transduction;Regulation of PTEN stability and activity;Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;PTEN Regulation;PIP3 activates AKT signaling;Deubiquitination;Intracellular signaling by second messengers
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- 0.769
- rvis_EVS
- -1.02
- rvis_percentile_EVS
- 8.04
Haploinsufficiency Scores
- pHI
- 0.233
- hipred
- Y
- hipred_score
- 0.747
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.894
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp13
- Phenotype
Zebrafish Information Network
- Gene name
- usp13
- Affected structure
- post-vent region
- Phenotype tag
- abnormal
- Phenotype quality
- curled
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;ubiquitin-dependent protein catabolic process;autophagy;cell population proliferation;regulation of autophagy;protein deubiquitination;melanocyte differentiation;protein K29-linked deubiquitination;protein K6-linked deubiquitination;protein stabilization;protein K63-linked deubiquitination;positive regulation of ERAD pathway;maintenance of unfolded protein involved in ERAD pathway
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;thiol-dependent ubiquitinyl hydrolase activity;ubiquitin binding;ubiquitin-like protein ligase binding;chaperone binding;proteasome binding;BAT3 complex binding;ubiquitin-specific protease activity involved in positive regulation of ERAD pathway